These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30461351)

  • 21. Co-existence of plasmid-mediated quinolone resistance determinants and mutations in gyrA and parC among fluoroquinolone-resistant clinical Enterobacteriaceae isolated in a tertiary hospital in Warsaw, Poland.
    Piekarska K; Wołkowicz T; Zacharczuk K; Rzeczkowska M; Chróst A; Bareja E; Olak M; Gierczyński R
    Int J Antimicrob Agents; 2015 Mar; 45(3):238-43. PubMed ID: 25468717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In Vitro Activity of Sitafloxacin and Additional Newer Generation Fluoroquinolones Against Ciprofloxacin-Resistant Neisseria gonorrhoeae Isolates.
    Hamasuna R; Ohnishi M; Matsumoto M; Okumura R; Unemo M; Matsumoto T
    Microb Drug Resist; 2018; 24(1):30-34. PubMed ID: 28581359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emergence of Proteus mirabilis harboring blaKPC-2 and qnrD in a Chinese Hospital.
    Hu YY; Cai JC; Zhang R; Zhou HW; Sun Q; Chen GX
    Antimicrob Agents Chemother; 2012 May; 56(5):2278-82. PubMed ID: 22354308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emergence of fluoroquinolone-resistant Propionibacterium acnes caused by amino acid substitutions of DNA gyrase but not DNA topoisomerase IV.
    Nakase K; Sakuma Y; Nakaminami H; Noguchi N
    Anaerobe; 2016 Dec; 42():166-171. PubMed ID: 27793740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of mutation distribution in DNA gyrase and topoisomerase IV genes in ciprofloxacin-non-susceptible Enterobacteriaceae isolated from blood cultures in a tertiary care university hospital in South Korea, 2005-2010.
    Nam YS; Cho SY; Yang HY; Park KS; Jang JH; Kim YT; Jeong JW; Suh JT; Lee HJ
    Int J Antimicrob Agents; 2013 Feb; 41(2):126-9. PubMed ID: 23265914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Presence of plasmid-mediated quinolone resistance determinants and mutations in gyrase and topoisomerase in Salmonella enterica isolates with resistance and reduced susceptibility to ciprofloxacin.
    Casas MR; Camargo CH; Soares FB; da Silveira WD; Fernandes SA
    Diagn Microbiol Infect Dis; 2016 May; 85(1):85-9. PubMed ID: 26971183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of full gyrA, gyrB, parC and parE gene sequences between all Ureaplasma parvum and Ureaplasma urealyticum serovars to separate true fluoroquinolone antibiotic resistance mutations from non-resistance polymorphism.
    Beeton ML; Chalker VJ; Kotecha S; Spiller OB
    J Antimicrob Chemother; 2009 Sep; 64(3):529-38. PubMed ID: 19567408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual targeting of topoisomerase IV and gyrase to reduce mutant selection: direct testing of the paradigm by using WCK-1734, a new fluoroquinolone, and ciprofloxacin.
    Strahilevitz J; Hooper DC
    Antimicrob Agents Chemother; 2005 May; 49(5):1949-56. PubMed ID: 15855518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the mechanisms of fluoroquinolone resistance in vancomycin-resistant enterococci of different origins.
    López M; Tenorio C; Del Campo R; Zarazaga M; Torres C
    J Chemother; 2011 Apr; 23(2):87-91. PubMed ID: 21571624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns of Fluoroquinolone Resistance in Enterobacteriaceae Isolated from the Assiut University Hospitals, Egypt: A Comparative Study.
    Abdel-Rahim MH; El-Badawy O; Hadiya S; Daef EA; Suh SJ; Boothe DM; Aly SA
    Microb Drug Resist; 2019 May; 25(4):509-519. PubMed ID: 30457926
    [No Abstract]   [Full Text] [Related]  

  • 31. qnrD, a novel gene conferring transferable quinolone resistance in Salmonella enterica serovar Kentucky and Bovismorbificans strains of human origin.
    Cavaco LM; Hasman H; Xia S; Aarestrup FM
    Antimicrob Agents Chemother; 2009 Feb; 53(2):603-8. PubMed ID: 19029321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In Vitro Resistance Development to Nemonoxacin in Streptococcus pneumoniae: A Unique Profile for a Novel Nonfluorinated Quinolone.
    Roychoudhury S; Makin K; Twinem T; Leunk R; Hsu MC
    Microb Drug Resist; 2016 Oct; 22(7):578-584. PubMed ID: 27267788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sitafloxacin: antimicrobial activity against ciprofloxacin-selected laboratory mutants of Mycoplasma genitalium and inhibitory activity against its DNA gyrase and topoisomerase IV.
    Deguchi T; Kikuchi M; Yasuda M; Ito S
    J Infect Chemother; 2015 Jan; 21(1):74-5. PubMed ID: 25245990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of multidrug-resistant Proteus mirabilis isolated from chicken carcasses.
    Wong MH; Wan HY; Chen S
    Foodborne Pathog Dis; 2013 Feb; 10(2):177-81. PubMed ID: 23351030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular characterization of antimicrobial susceptibility of Salmonella isolates: First identification of a plasmid carrying qnrD or oqxAB in Taiwan.
    Kao CY; Chen CA; Liu YF; Wu HM; Chiou CS; Yan JJ; Wu JJ
    J Microbiol Immunol Infect; 2017 Apr; 50(2):214-223. PubMed ID: 26055690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quinolone Resistance Mechanisms Among Salmonella enterica in Malaysia.
    Thong KL; Ngoi ST; Chai LC; Teh CS
    Microb Drug Resist; 2016 Jun; 22(4):259-72. PubMed ID: 26683630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in the GyrA and GyrB subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa.
    Lee JK; Lee YS; Park YK; Kim BS
    Int J Antimicrob Agents; 2005 Apr; 25(4):290-5. PubMed ID: 15784307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of mutations within the quinolone resistance-determining region of gyrA, gyrB, parC, and parE and association with antibiotic resistance in quinolone-resistant Salmonella enterica.
    Eaves DJ; Randall L; Gray DT; Buckley A; Woodward MJ; White AP; Piddock LJ
    Antimicrob Agents Chemother; 2004 Oct; 48(10):4012-5. PubMed ID: 15388468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Fluoroquinolone resistance mutations in topoisomerase genes of Salmonella typhimurium isolates].
    Guo Y; Pei X; Liu X
    Wei Sheng Yan Jiu; 2004 Sep; 33(5):591-4. PubMed ID: 15612489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Genetical conditioning of fluoroquinolone resistance mechanisms of clinical enterococcus faecalis strains. II. The mutations present in the qrdrs of gyrA, gyrB, parC and parE genes].
    Piekarska K; Jagielski M
    Med Dosw Mikrobiol; 2007; 59(4):329-41. PubMed ID: 18416125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.